Is BioSyent Inc halal to invest in?

As of July 2026, BioSyent Inc RX.V is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is BioSyent Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BioSyent Inc using these criteria to determine its compliance status.

Can Muslims buy shares of BioSyent Inc?

Muslim investors may consider investing in BioSyent Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is BioSyent Inc classified as HALAL?

Musaffa determines the Shariah status of BioSyent Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for BioSyent Inc updated?

The Shariah compliance status of BioSyent Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like BioSyent Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of BioSyent Inc?

You can check the latest Shariah compliance status of BioSyent Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

BioSyent Inc RX.V

Last Updated: Jul 22, 12:00 AM·TSX

RX.V Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, BioSyent Inc is classified as halal.

HALAL

Report Source: 2025 Annual Report

BioSyent Inc. Stock Analysis RX.V

Canada Health Care Micro Cap Report: 2025 Annual

BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. The company is headquartered in Mississauga, Ontario. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., sources, acquires or in-licenses and further develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., and Hedley Technologies (USA) Inc., a wholly owned subsidiary, operates the Company’s business marketing biologically and health-friendly non-chemical insecticides. The Company’s products include Combogesic, Cathejell, FeraMAX Pd Therapeutic 150, FeraMAX Pd Maintenance 45, FeraMAX Pd Powder 15, Gelclair, Inofolic, Proktis-M, RepaGyn and Tibella, among others. Combogesic is for the short-term management of mild to moderate acute pain and the reduction of fever in adults. FeraMAX Pd Therapeutic 150 is for the treatment of iron deficiency anemia. The firm also provides specialized healthcare products for dental hygiene and oral health.

Key Statistics of BioSyent Inc (RX.V)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD14.54CAD14.70

Today's Open

CAD14.70

Volume

8087.00

P/E Ratio (TTM)

18.66

52 Week Range

CAD10.65CAD15.80

Market Cap

164.94M

Avg. Volume

8636.62

Dividend Yield

1.37%

Financial Metrics & Statements of BioSyent Inc (RX.V)

Super Investors Invested in BioSyent Inc (RX.V)

FAQ's for BioSyent Inc (RX.V)

As of July 2026, BioSyent Inc RX.V is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes BioSyent Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in BioSyent Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of BioSyent Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of BioSyent Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of BioSyent Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.